HHS Launches Newborn Essentials Support Toolkit Program to Support Mothers and Babies

• by Assistant Secretary for Public Affairs (ASPA)

• October 9, 2026

Is the reported benefit of the Endo-App truly sustained?

• by Zahide Küçük

• October 1, 2026

FDA approves pritelivir for refractory HSV lesions

In a phase 3 trial, complete lesion healing occurred in 63% of patients receiving pritelivir vs. 34% receiving comparator treatments.

• by Teraya Smith

• October 9, 2026

• 2 min

Women’s Access to Fertility Care

• by Usha Ranji, Karen Diep, Brittni Frederiksen, Ivette Gomez, Alina Salganicoff

• October 8, 2026